[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Diltiazem ER |
Cardizem CD; Cardizem LA; Cardizem SR; Cartia XT; Dilacor XR; Diltia XT; Taztia XT; Tiamate; Tiazac |
Clinical Trial: Tailored Teen Alcohol and Violence Prevention in the ER
This study is not yet open for patient recruitment.
Verified by University of Michigan November 2005
|
Purpose
| Condition | Intervention |
|---|---|
| Violence Alcohol Abuse | Behavior: Adapted Motivational Interviewing & Skills Training |
MedlinePlus related topics: Alcoholism
Study Type: Interventional
Study Design: Prevention, Randomized, Single Blind, Active Control, Factorial Assignment, Efficacy Study
Secondary Outcomes: Secondary outcome measures include illicit drug use, unintentional injury, delinquency and weapon carriage.
Expected Total Enrollment: 3000
Study start: May 2006; Expected completion: March 2010
Last follow-up: December 2009; Data entry closure: March 2010
Eligibility
Inclusion Criteria:
- adolescents (ages 14-18) presenting to the ED for a medical injury or illness (except exclusions as noted below)
- adolescents ability to provide informed assent/consent depending on age
- access to a parent or guardian to provide informed consent
Exclusion Criteria:
- adolescents who do not understand English
- prisoners
- adolescents classified by medical staff as “Level 1” trauma
- adolescents deemed unable to provide informed consent
- adolescents treated in the ED for suicide attempts
- adolescents triaged to the psychiatric ED
Location and Contact Information
Michigan
Hulrey Medical Center, Flint, Michigan, 48503, United States
Maureen Walton, PhD, MPH, Principal Investigator, University of Michigan
More Information
Last Updated: December 8, 2005
Record first received: November 7, 2005
ClinicalTrials.gov Identifier: NCT00251212
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2006-01-10
Resources
- Cardizem CD (Drug Digest)
- Cardizem LA (Drug Digest)

Not Signed In -


